0001104659-23-035192.txt : 20230321
0001104659-23-035192.hdr.sgml : 20230321
20230321183902
ACCESSION NUMBER: 0001104659-23-035192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230317
FILED AS OF DATE: 20230321
DATE AS OF CHANGE: 20230321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoffman Marc L
CENTRAL INDEX KEY: 0001795312
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23661
FILM NUMBER: 23750837
MAIL ADDRESS:
STREET 1: 30142 WIXOM ROAD
CITY: WIXOM
STATE: MI
ZIP: 48393
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCKWELL MEDICAL, INC.
CENTRAL INDEX KEY: 0001041024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383317208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30142 WIXOM ROAD
CITY: WIXOM
STATE: MI
ZIP: 48393
BUSINESS PHONE: 8004493353
MAIL ADDRESS:
STREET 1: 30142 WIXOM ROAD
CITY: WIXOM
STATE: MI
ZIP: 48393
FORMER COMPANY:
FORMER CONFORMED NAME: ROCKWELL MEDICAL TECHNOLOGIES INC
DATE OF NAME CHANGE: 20120530
FORMER COMPANY:
FORMER CONFORMED NAME: ROCKWELL MEDICAL, INC.
DATE OF NAME CHANGE: 20120525
FORMER COMPANY:
FORMER CONFORMED NAME: ROCKWELL MEDICAL TECHNOLOGIES INC
DATE OF NAME CHANGE: 19970722
4
1
tm2310125-3_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-03-17
0
0001041024
ROCKWELL MEDICAL, INC.
RMTI
0001795312
Hoffman Marc L
C/O ROCKWELL MEDICAL, INC.
30142 S. WIXOM ROAD
WIXOM
MI
48393
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-03-17
4
A
0
25665
0
A
25665
D
Stock Option (Right to Buy)
1.37
2023-03-17
4
A
0
32990
0
A
2033-03-17
Common Stock
32990
32990
D
Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders.
Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders.
/s/ David Kull, Attorney-in-Fact for Marc L. Hoffman
2023-03-21